Fly News Breaks for July 30, 2019
Jul 30, 2019 | 09:27 EDT
Craig-Hallum analyst Per Ostlund raised his price target for Exact Sciences to $127 from $115 following "exceptional" Q2 results that were overshadowed by the planned Genomic Health acquisition. The analyst reiterates a Buy rating on the shares and thinks management has earned investors' faith.
News For EXAS From the Last 2 Days
There are no results for your query EXAS